Incretin-Based Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-2051 | Report Format : | Status : Upcoming |

Abstract

Global Incretin-Based Drugs Market: Overview

When the blood glucose levels decrease a group of metabolic hormones is stimulated which is known as incretins. Incretin-based drugs include glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors which are the new group of drugs that are helpful in curing type 2 diabetes. These drugs have a positive effect on the body weight and have a low risk of hypoglycemia. The oral anti-diabetic drugs are unable to maintain the desired levels of glucose, especially during the conditions of postprandial, thus increasing the requirement for a better therapeutics such as the incretin-based drugs. The consumption of the incretin-based drugs increases the secretion of insulin and inhibits the release of glucagon.

Global Incretin-Based Drugs Market: Segmentation

The global market for the incretin-based drugs is fragmented into its drug type, formulation, and distribution channel. Depending on the drug type, the global market is segregated into dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor (GLP-1) agonists. Depending on the formulation, the market is categorized into injectable drugs and oral drugs. Depending on the distribution channel, the market is divided into online pharmacies, hospital pharmacies, retail pharmacies, and others.

Global Incretin-Based Drugs Market: Growth Factors

The key factors that are driving the incretin-based drugs market are rising old age population, increased rate of obesity, sedentary lifestyle, increasing rate of people suffering from cardiovascular diseases and diabetes, and the increasing awareness among the people. The other factor that is driving the growth of the market is the rise in the number of patients that are undiagnosed and pre-diagnosed for the disease. There are certain factors that will restrain the growth of the market which include the absence of supportive reimbursement policies, lack of accessibility to the drugs, a high cost that is involved in the treatment and the increased safety concerns affect the market growth negatively.

Global Incretin-Based Drugs Market: Regional Analysis

According to the regional study, the global market for the incretin-based drugs is diversified into Eastern Europe, North America, Western Europe, Asia Pacific, the Middle East and Africa, and Latin America. There is an increased demand for the incretin-based drugs in the Asia Pacific region. While North America and Western European region are considered as lucrative markets for the incretin-based drugs due to the increased awareness about diabetes and the good management of the disease. The growth of the incretin-based drugs market is majorly influenced by the supportive policies that are implemented by the government. In many of the countries, the governments are providing support to the weaker sections of the society to have the access to the diabetes drugs so that they have access to quality healthcare.

Global Incretin-Based Drugs Market: Competitive Players

The key market players that are involved in the incretin-based drugs market include Boehringer Ingelheim GmbH., GlaxoSmithKline Plc., Merck & Co., Inc., Takeda Pharmaceutical Company Ltd., Sanofi S.A., AstraZeneca Plc., Eli Lilly and Company, Johnson & Johnson, and Novartis AG.

Global Incretin-Based Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Veterinary Anti-Infectives Market by Species Type (Livestock and Companion), by Drug Class (Antimicrobial, Antiviral, Antifungal and Antiparasitic Agents), by Mode of Administration (Oral, Parenteral and Topical) and End-users (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2510 | Report Format:

The report covers forecast and analysis for the veterinary anti-infectives market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the veterinary anti-infectiv...Read More

Acromegaly Treatment Market by Disease type (Ectopic Acromegaly and Pseudo Acromegaly), Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery and Radiation Therapy: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2507 | Report Format:

The report covers forecast and analysis for the acromegaly treatment market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the acromegaly treatment market al...Read More

year end sale
Choose License Type:
Latest Published Reports

View All Published Reports